Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Linhardt

Showing results (131-140 of 207) with videos related to

Pageof 21
Sort By:
Carbohydrate Research|February 17, 1992
Analysis of glycosaminoglycan-derived oligosaccharides using fast-atom-bombardment mass-spectrometryR J Linhardt, H M Wang, D Loganathan, et al.
Science (New York, N.Y.)|February 23, 1996
Heparin structure and interactions with basic fibroblast growth factorS Faham, R E Hileman, J R Fromm, et al.
Biochemical Pharmacology|March 29, 1994
Low molecular weight dermatan sulfate as an antithrombotic agent. Structure-activity relationship studiesR J Linhardt, U R Desai, J Liu, et al.
Analytical Biochemistry|August 15, 1992
An electrophoresis-based assay for glycosyltransferase activityK B Lee, U R Desai, M M Palcic, et al.
Analytical Biochemistry|February 1, 1984
Metachromatic activity of heparin and heparin fragmentsA C Grant, R J Linhardt, G L Fitzgerald, et al.
Analytical Biochemistry|November 1, 1985
High-performance liquid chromatographic separation of heparin-derived oligosaccharidesK G Rice, Y S Kim, A C Grant, et al.
The Journal of Biological Chemistry|September 15, 1988
Homogeneous, structurally defined heparin-oligosaccharides with low anticoagulant activity inhibit the generation of the amplification pathway C3 convertase in vitroR J Linhardt, K G Rice, Y S Kim, et al.
Archives of Biochemistry and Biophysics|July 5, 2001
Certain high molecular weight heparin chains have high affinity for vitronectinR E Edens, L A LeBrun, R J Linhardt, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1982
In vivo activity of microbial heparinaseR Langer, R J Linhardt, A K Larsen, et al.
Biochemistry|December 15, 1992
Isolation and characterization of human heparinR J Linhardt, S A Ampofo, J Fareed, et al.
Pageof 21

Showing results (131-140 of 207) with videos related to

Sort By:
Pageof 21
Carbohydrate Research|February 17, 1992
Analysis of glycosaminoglycan-derived oligosaccharides using fast-atom-bombardment mass-spectrometryR J Linhardt, H M Wang, D Loganathan, et al.
Science (New York, N.Y.)|February 23, 1996
Heparin structure and interactions with basic fibroblast growth factorS Faham, R E Hileman, J R Fromm, et al.
Biochemical Pharmacology|March 29, 1994
Low molecular weight dermatan sulfate as an antithrombotic agent. Structure-activity relationship studiesR J Linhardt, U R Desai, J Liu, et al.
Analytical Biochemistry|August 15, 1992
An electrophoresis-based assay for glycosyltransferase activityK B Lee, U R Desai, M M Palcic, et al.
Analytical Biochemistry|February 1, 1984
Metachromatic activity of heparin and heparin fragmentsA C Grant, R J Linhardt, G L Fitzgerald, et al.
Analytical Biochemistry|November 1, 1985
High-performance liquid chromatographic separation of heparin-derived oligosaccharidesK G Rice, Y S Kim, A C Grant, et al.
The Journal of Biological Chemistry|September 15, 1988
Homogeneous, structurally defined heparin-oligosaccharides with low anticoagulant activity inhibit the generation of the amplification pathway C3 convertase in vitroR J Linhardt, K G Rice, Y S Kim, et al.
Archives of Biochemistry and Biophysics|July 5, 2001
Certain high molecular weight heparin chains have high affinity for vitronectinR E Edens, L A LeBrun, R J Linhardt, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1982
In vivo activity of microbial heparinaseR Langer, R J Linhardt, A K Larsen, et al.
Biochemistry|December 15, 1992
Isolation and characterization of human heparinR J Linhardt, S A Ampofo, J Fareed, et al.
Pageof 21